Credence Medsystems
1600 Adams Drive
Suite 235
Menlo Park
California
94025
United States
Tel: 844-263-3797
Website: http://www.credencemed.com/
Email: info@credencemed.com
About Credence Medsystems
Credence MedSystems is a drug delivery technology company focused on delivering medications safely for the benefit of patients, caregivers and partners. The Companion Safety Syringe System was born from Credence’s philosophy of Innovation Without Change. The Companion offers our biotechnology and pharmaceutical partners a simplified path to commercialization of a best-in-class delivery system by providing passive needle safety and reuse prevention while using existing primary package components.YEAR FOUNDED:
2011
LEADERSHIP:
CEO: Jeff Shanley
CCO: John A. Merhige
COO: Jeff Tillack
PRODUCTS:
All Products
9 articles about Credence Medsystems
-
Credence MedSystems Announces a Significant Milestone Towards Scaling Manufacturing Capabilities
1/18/2024
Credence MedSystems announced that it has successfully completed Factory Acceptance Testing for production of its Companion® injection device platform on the Company's new Clinical Assembly Line.
-
Credence MedSystems Announces Strategic Collaboration With Phillips-Medisize
10/19/2021
Credence MedSystems, Inc. announced today that it has formed a strategic collaboration with Phillips-Medisize, a Molex company, a global leader in the design and manufacturing of solutions for the pharmaceutical drug delivery market.
-
Credence MedSystems Secures $39.9 Million Financing to Enable Scaling of Innovative Drug Delivery and Connected Health Systems
9/22/2021
Credence MedSystems, Inc. announced today that it has closed a funding round with gross proceeds of $39.9 million. Sources of funding include strategic investments from Novartis Pharma AG, Molex Ventures LLC as well as additional investors.
-
Credence MedSystems Receives a Strategic Investment From One of the World’s Leading Pharmaceutical Companies
1/26/2021
Novartis has invested in Credence, confirming its interest in employing Credence technology for its injectable medicines. The investment is geared towards supporting Credence’s ramp-up of manufacturing capacity for its innovative drug delivery systems and enabling commercial supply of Credence devices to the pharmaceutical market.
-
SCHOTT AG and Credence MedSystems Form a Strategic Collaboration Agreement to Make Syringe Injections Safer for the Benefit of Patients Worldwide
10/5/2020
Credence MedSystems and SCHOTT AG have formed a collaboration for the application of Credence Companion® technology with SCHOTT’s pre-fillable syriQ® glass and SCHOTT TOPPAC® polymer syringe systems.
-
Credence MedSystems Receives Award for Best Innovation in Drug Delivery Devices
2/13/2020
Credence MedSystems, an innovator in injectable drug delivery technology for the biopharmaceutical industry, has received the Pharmapack Award for its Connect™ Auto-Sensing Injection System.
-
Credence MedSystems Awarded Grant to Develop Its Dual Chamber Drug Delivery Device for the Global Health Setting
10/16/2019
Funding will support development of Credence’s Dual Chamber Reconstitution Syringe
-
Credence MedSystems Closes $12.8 Million Series B Financing
8/7/2018
Funding will support ongoing development and scaling of Credence’s family of innovative drug delivery products
-
Bay Area's Credence Scores $15 Million in Financing
9/13/2016